- Published on
Emergency and Acute Medicine - Serotonin Syndrome (Drug-Induced)
Serotonin syndrome is a clinical condition caused by excessive stimulation of central and peripheral serotonergic receptors. It presents as a spectrum ranging from mild symptoms to severe, life-threatening toxicity. The condition typically results from the use of serotonergic medications, either alone, in overdose, or more commonly through drug interactions. The classic triad includes autonomic dysfunction (such as hyperthermia, diaphoresis, tachycardia, and hypertension), cognitive or behavioral changes (including agitation, confusion, hallucinations, or decreased responsiveness), and neuromuscular hyperactivity (such as hyperreflexia, clonus, tremor, and myoclonus).
Serotonin syndrome is most frequently associated with psychiatric medications, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Other implicated agents include monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, opioids (e.g., fentanyl, tramadol, methadone), antiemetics like ondansetron, and substances such as cocaine and MDMA (ecstasy). Herbal supplements like St. John’s wort may also contribute. The condition is more common in young adults and has a higher incidence in females, although fatalities are more common in males. Most severe cases result from drug interactions or recreational drug use.
Diagnosis is clinical and relies heavily on history and physical examination. The Hunter criteria are the most sensitive and specific diagnostic tool and require recent exposure to a serotonergic agent along with features such as clonus (spontaneous, inducible, or ocular), agitation, diaphoresis, tremor with hyperreflexia, or hypertonia with hyperthermia. Patients may present with hyperthermia, tachycardia, hypertension or hypotension, diaphoresis, and gastrointestinal symptoms such as diarrhea. Neurologically, agitation, delirium, hallucinations, and characteristic findings like clonus and hyperreflexia—especially in the lower extremities—are key diagnostic clues.
Laboratory testing is not diagnostic but helps assess severity and exclude other conditions. Tests may include electrolytes, renal function, creatine kinase, lactate, and toxicology screens. Imaging such as CT of the head may be considered if alternative diagnoses like trauma or intracranial pathology are suspected. Electrocardiography is useful to evaluate for arrhythmias or conduction abnormalities. Differential diagnoses include neuroleptic malignant syndrome, malignant hyperthermia, anticholinergic toxicity, sympathomimetic toxicity, and central nervous system infections such as meningitis or encephalitis.
Management focuses on supportive care and prompt recognition. Initial stabilization includes airway management, oxygen, IV access, and continuous monitoring of vital signs and temperature. All serotonergic agents must be discontinued immediately. Benzodiazepines such as lorazepam or diazepam are first-line treatments to control agitation and neuromuscular symptoms. Aggressive cooling measures are essential in cases of hyperthermia, which results from increased muscle activity rather than hypothalamic set-point changes, making antipyretics ineffective.
In severe cases, especially with uncontrollable hyperthermia or significant rigidity, intubation and paralysis may be required. Cyproheptadine, a serotonin antagonist, may be considered in severe cases, although evidence of its benefit is limited and it is only available in oral form. Consultation with a poison control center or toxicologist is recommended.
All patients with suspected serotonin syndrome should be admitted for monitoring, even if symptoms appear mild. Severe cases with instability, significant hyperthermia, or altered mental status require ICU care. Patients may be discharged once symptoms have completely resolved, with careful review of medications and education to prevent recurrence. Early recognition, discontinuation of offending agents, and supportive management are key to favorable outcomes.
0 Comments
